4th Ligase Targeting Drug Development Summit
Successfully Progressing Towards Efficacious Degrader Drugs with Novel Ligases & Ligands
The development of mono- and bivalent degraders continues to gain traction, but biopharma faces challenges in rapidly discovering, validating, and utilizing novel E3 ligases. This leaves therapeutic opportunities untapped due to obstacles in ligase screening, structural characterization, and assaying therapeutic efficacy.
The Annual Ligase Targeting Drug Development Summit, now in its 4th year, will unite 80+ ligase experts dedicated to tackling ligase bottlenecks through data-driven presentations, technical discussions, and interactive sessions, unlocking the potential of E3 ligases for novel drug targets.
Ligase Expert Speakers
Chief Scientific Officer
Co Founder and Chief Executive Officer
Principal Research Scientist
What's New for 2024?
EXTENSIVE TECHNICAL CONTENT
Covering the latest advances in ligase ligand screening, biophysical characterization, and validating the next wave of degrading and modulating drugs with improved selectivity and safety.
A NEW COHORT OF SPEAKERS
Presenting from the likes of AbbVie, Lyterian Therapeutics, NysnoBio & the Max Planck Institute.
'Spearheading Time-Resolved Cryo-EM to Integrate Structural
Dynamics Studies into Ligase-Targeted Drug Discovery'
With The Francis Crick Institute
Present Your Work!
Our poster sessions are a valuable opportunity to interact and exchange new information with your peers. A poster is a great way to showcase your work, generate discussion, spark an interesting debate and bring awareness to important issues within the industry.
Taking place on Conference Day Two (Thursday, May 9), the poster session is reserved exclusively for drug developers, academics and clinicians and will give you the chance to showcase your research.
*There is no additional charge, but we ask that poster displays are not used for sales or marketing purposes. All poster abstracts are subject to approval by the conference organisers. You must be an attendee to submit an abstract.
Once your abstract is approved, the event organisers will be in touch with further details.
>> Poster Submission Deadline: Monday, April 13, 2024 <<
If you have any questions, please email firstname.lastname@example.org